Italia markets open in 4 hours 6 minutes

JNJ May 2024 150.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
4,7500+0,7300 (+18,16%)
In data: 03:58PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente4,0200
Aperto3,6100
Denaro3,5500
Lettera5,3000
Prezzo d'esercizio150,00
Scadenza2024-05-31
Min-Max giorno3,6100 - 4,7500
Contratto - Min-MaxN/D
Volume3.174
Open Interest472
  • GlobeNewswire

    Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara®

    According to the settlement agreement, AVT04 (ustekinumab) can be marketed in the US, subject to regulatory approval, no later than February 21, 2025 REYKJAVIK, Iceland and TEL AVIV, Israel and PARSIPPANY, N.J., June 12, 2023 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA